Seidlin Consulting LLC provides strategic consulting services
to the pharmaceutical and  biotechnology industry and contributes to the development of novel therapies by assisting companies in planning and executing focused development strategies that will succeed in achieving corporate goals such
as  garnering regulatory approvals, attracting development partners or venture capital. We also guide companies in creating strong, flexible structures to manage development programs
and contract research organizations in compliance with legal
and regulatory expectations.

Consulting services include:

•  Design or optimization of development strategy and protocols
    for US and  global regulators and markets.

•  Prioritizing drug portfolios

•  Creation and management of expert panels

•  Analyses of clinical and regulatory risk for new drug products

•  Evaluation of in-licensing candidates at any stage of development

•  Advice regarding strategic partnerships and alliances
    with corporate entities

•  Advising management in preparation for presentations to
    analysts, capital investment groups and regulatory agencies